Search Results
Search for other papers by Yuanliang Li in
Google Scholar
PubMed
Search for other papers by Yiying Guo in
Google Scholar
PubMed
Search for other papers by Zixuan Cheng in
Google Scholar
PubMed
Search for other papers by Chao Tian in
Google Scholar
PubMed
Search for other papers by Yingying Chen in
Google Scholar
PubMed
Search for other papers by Ruao Chen in
Google Scholar
PubMed
Search for other papers by Fuhuan Yu in
Google Scholar
PubMed
Search for other papers by Yanfen Shi in
Google Scholar
PubMed
Search for other papers by Fei Su in
Google Scholar
PubMed
Search for other papers by Shuhua Zhao in
Google Scholar
PubMed
Search for other papers by Zhizheng Wang in
Google Scholar
PubMed
Search for other papers by Jie Luo in
Google Scholar
PubMed
Department of Integrative Oncology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
Search for other papers by Huangying Tan in
Google Scholar
PubMed
). According to the differentiation, they can be classified as well-differentiated rectal neuroendocrine tumors (R-NETs) and poorly differentiated neuroendocrine carcinomas (R-NECs). In recent years, several drugs or treatment strategies have been developed for
Search for other papers by Nicole Panarelli in
Google Scholar
PubMed
Search for other papers by Kathrin Tyryshkin in
Google Scholar
PubMed
Search for other papers by Justin Jong Mun Wong in
Google Scholar
PubMed
Search for other papers by Adrianna Majewski in
Google Scholar
PubMed
Search for other papers by Xiaojing Yang in
Google Scholar
PubMed
Search for other papers by Theresa Scognamiglio in
Google Scholar
PubMed
Search for other papers by Michelle Kang Kim in
Google Scholar
PubMed
Search for other papers by Kimberly Bogardus in
Google Scholar
PubMed
Search for other papers by Thomas Tuschl in
Google Scholar
PubMed
Search for other papers by Yao-Tseng Chen in
Google Scholar
PubMed
HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA
Search for other papers by Neil Renwick in
Google Scholar
PubMed
Digestive Tract ( Bosman et al . 2010 ). Four additional cases of low-grade rectal carcinoid tumors were obtained (through MK) from the Center for Carcinoid and Neuroendocrine Tumors of Mount Sinai, Icahn School of Medicine at Mount Sinai. Representative
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
Introduction Neuroendocrine tumors comprise a diverse group of malignancies and, when defined broadly, include not only gastrointestinal neuroendocrine tumors but also pheochromocytoma, thyroid cancer, and even small cell lung
Università Cattolica del Sacro Cuore, Rome, Italy
ENETS Center of Excellence, Neuroendocrine Tumour (NET) Center, Rome, Italy
Search for other papers by Guido Rindi in
Google Scholar
PubMed
ENETS Center of Excellence, Neuroendocrine Tumour (NET) Center, Rome, Italy
Search for other papers by Frediano Inzani in
Google Scholar
PubMed
based on the common expression of the general markers of neuroendocrine differentiation chromogranin A and synaptophysin. NEN definition embraces the two families (classes) of the well-differentiated lesions, defined as neuroendocrine tumor (NET), and
Search for other papers by Yeting Du in
Google Scholar
PubMed
Dana-Farber Cancer Institute, Boston, Massachusetts
Search for other papers by Monica Ter-Minassian in
Google Scholar
PubMed
Search for other papers by Lauren Brais in
Google Scholar
PubMed
Search for other papers by Nichole Brooks in
Google Scholar
PubMed
Search for other papers by Amanda Waldron in
Google Scholar
PubMed
Search for other papers by Jennifer A Chan in
Google Scholar
PubMed
Search for other papers by Xihong Lin in
Google Scholar
PubMed
Search for other papers by Peter Kraft in
Google Scholar
PubMed
Massachusetts General Hospital, Boston, Massachusetts, USA
Search for other papers by David C Christiani in
Google Scholar
PubMed
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
lungs and bronchi, which account for up to 30% of all neuroendocrine tumors, with small intestine, appendix and rectal carcinoid tumors comprising the majority of the remaining sites ( Yao et al . 2008 ). Within the gastrointestinal tract, carcinoid
Search for other papers by M Fraenkel in
Google Scholar
PubMed
Search for other papers by M Kim in
Google Scholar
PubMed
Endocrinology, Mount Sinai Medical Center, Department of Clinical Medicine and Surgery, Endocrinology, Erasmus MC, Department of Internal Medicine, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheeba, Israel
Search for other papers by A Faggiano in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
Search for other papers by G D Valk in
Google Scholar
PubMed
Search for other papers by On behalf of the Knowledge NETwork in
Google Scholar
PubMed
’(Mesh)) OR ‘Prevalence’(Mesh)) AND ((‘Neuroendocrine Tumors’(Mesh) OR ‘Carcinoma, Neuroendocrine’(Mesh) OR ‘Gastro-enteropancreatic neuroendocrine tumor’ (Supplementary Concept)) OR ((neuroendocrine AND (tumors OR tumour)) OR (neuro-endocrine AND (tumors OR
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Reina Sofia University Hospital, Córdoba, Spain
Search for other papers by Aura D Herrera-Martínez in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Search for other papers by María A Gálvez Moreno in
Google Scholar
PubMed
Search for other papers by Justo P Castaño in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
original articles, were included. The following search terms, alone or in combination, were used: ‘biomarkers’, ‘novel markers’, ‘neuroendocrine tumors’, ‘NETs’, ‘neuroendocrine neoplasms’, ‘NENs’, ‘circulating markers’, ‘tissue markers’, ‘therapeutic
Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), Marseille, France
Department of Endocrinology, Assistance Publique – Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares Hypophysaires HYPO, Marseille, France
Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Search for other papers by Wouter de Herder in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique – Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares Hypophysaires HYPO, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
distributions of small intestine neuroendocrine tumors (SI-NETs) and rectal NETs differ between region of the world, genders and ethnicities ( Fig. 1 ) ( Hauso et al. 2008 , Yao et al. 2008 , Ito et al. 2010 , Landerholm et al. 2010 , Taghavi et al
Member of the German Cancer Consortium (DKTK), Germany
Search for other papers by Atsuko Kasajima in
Google Scholar
PubMed
Search for other papers by Günter Klöppel in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) arise from various anatomical sites in the body but share basic features. NENs consist of two main families, well-differentiated NENs, also called neuroendocrine tumors (NETs) or carcinoids, and
Search for other papers by Tanupriya Contractor in
Google Scholar
PubMed
Search for other papers by Richard Clausen in
Google Scholar
PubMed
Search for other papers by Grant R Harris in
Google Scholar
PubMed
Search for other papers by Jeffrey A Rosenfeld in
Google Scholar
PubMed
Search for other papers by Darren R Carpizo in
Google Scholar
PubMed
Search for other papers by Laura Tang in
Google Scholar
PubMed
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA
Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Search for other papers by Chris R Harris in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) can occur throughout the body, within the many organs that contain hormone-producing cells. Tumors found in these various locations can share common genetic drivers, as indicated by the fact that